Stability of pemetrexed diarginine concentrates for solution in vials and diluted in 0.9% sodium chloride and dextrose 5% polyolefin infusion bags
10.1136/ejhpharm-2020-002620
March 3, 2021
EAHP Statement 3: Production and Compounding
Formulation and stability of an extemporaneously compounded propafenone hydrochloride oral suspension for children with arrhythmia
10.1136/ejhpharm-2020-002567
February 19, 2021
Science- and risk-based strategy to qualify prefillable autoclavable syringes as primary packaging material
10.1136/ejhpharm-2020-002333
January 27, 2021
Formulation, long-term physicochemical and microbiological stability of 15% topical resorcinol for hidradenitis suppurativa
10.1136/ejhpharm-2020-002534
December 16, 2020
Lopinavir/ritonavir, a new galenic oral formulation from commercial solid form, fine-tuned by nuclear magnetic resonance spectroscopy
10.1136/ejhpharm-2020-002389
November 19, 2020
High concentrated etoposide solutions, additional physical stability data in dextrose 5%
10.1136/ejhpharm-2020-002468
October 20, 2020
External contamination of antineoplastic drug vials: an occupational risk to consider
10.1136/ejhpharm-2020-002440
September 25, 2020
Results of EAHP’s 2019 Medicines Shortages Survey
10.1136/ejhpharm-2020-002341
May 29, 2020
Reducing the risk of non-sterility of aseptic handling in hospital pharmacies, part A: risk assessment
10.1136/ejhpharm-2019-002178
May 8, 2020
Reducing the risk of non-sterility of aseptic handling in hospital pharmacies, part B: risk control
10.1136/ejhpharm-2019-002179
May 8, 2020